Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

× No keyword cloud information.

9 in total

1. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Authors: Sean van Diepen; Matthew T Roe; Renato D Lopes; Amanda Stebbins; Stefan James; L Kristin Newby; David J Moliterno; Franz-Josef Neumann; Justin A Ezekowitz; Kenneth W Mahaffey; Judith S Hochman; Christian W Hamm; Paul W Armstrong; Pierre Theroux; Christopher B Granger
Journal: J Thromb Thrombolysis Date: 2012-07 Impact factor: 2.300

2. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.

Authors: Sean van Diepen; Wendimagegn G Alemayehu; Yinggan Zheng; Pierre Theroux; L Kristin Newby; Kenneth W Mahaffey; Christopher B Granger; Paul W Armstrong
Journal: J Thromb Thrombolysis Date: 2016-10 Impact factor: 2.300

3. Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.

Authors: Jay S Shavadia; Wendimagegn Alemayehu; Christopher deFilippi; Cynthia M Westerhout; Jasper Tromp; Christopher B Granger; Paul W Armstrong; Sean van Diepen
Journal: J Thromb Thrombolysis Date: 2021-10-27 Impact factor: 2.300

4. Surgical management for mechanical complications of acute myocardial infarction: a systematic review of long-term outcomes.

Authors: Sarah Yousef; Ibrahim Sultan; Helena M VonVille; Kevin Kahru; George J Arnaoutakis
Journal: Ann Cardiothorac Surg Date: 2022-05

5. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.

Authors: Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Journal: Eur Heart J Date: 2009-06-06 Impact factor: 29.983

6. Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.

Authors: Sean van Diepen; Petr Widimsky; Renato D Lopes; Kyle R White; W Douglas Weaver; Frans Van de Werf; Diego Ardissino; Arnoud W J van't Hof; Paul W Armstrong; Christopher B Granger
Journal: Circ Cardiovasc Qual Outcomes Date: 2012-05-15

Review 7. Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.

Authors: Bruno Ramos Nascimento; Marcos Roberto de Sousa; Fábio Nogueira Demarqui; Antonio Luiz Pinho Ribeiro
Journal: ISRN Cardiol Date: 2014-02-06

8. Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention.

Authors: Jay S Shavadia; Christopher B Granger; Wendimagegn Alemayehu; Cynthia M Westerhout; Thomas J Povsic; Sean Van Diepen; Christopher Defilippi; Paul W Armstrong
Journal: J Am Heart Assoc Date: 2020-06-17 Impact factor: 5.501

Review 9. Complement activation: an emerging player in the pathogenesis of cardiovascular disease.

Authors: Angela M Carter
Journal: Scientifica (Cairo) Date: 2012-12-16

9 in total